Samidorphan Related Products


SynZeal is a leading innovator in pharmaceutical reference standards. We supply high-quality Reference Standards of Samidorphan, pharmacopeial and non-pharmacopeial Samidorphan impurities, metabolites, stable isotope products, and nitrosamines (N-NO products). Samidorphan impurities reference standards are useful in pharmaceutical research. They are useful in product development, ANDA and DMF filing, quality control (QC), method validation, and stability studies. It is also useful in the identification of unknown impurities and the assessment of genotoxic potential.

Samidorphan-related products are thoroughly characterized. Samidorphan products are supplied with detailed COA & analytical data meeting regulatory compliance. We can also provide EP/USP traceable standards based on your requirements. The supplied products are re-tested at regular intervals.

Samidorphan

SZ目录编号:: SZ-S083001
CAS 号: 852626-89-2
分子式: C21H26N2O4
分子量: 370.4
投资状态: Custom Synthesis

Samidorphan Butyl Impurity

SZ目录编号:: SZ-S083007
CAS 号: NA
分子式: C21H28N2O4
分子量: 372.5
投资状态: Custom Synthesis

Samidorphan Impurity 1

SZ目录编号:: SZ-S083002
CAS 号: 886588-56-3
分子式: C21H28N2O3
分子量: 356.5
投资状态: Custom Synthesis

Samidorphan Impurity 2

SZ目录编号:: SZ-S083003
CAS 号: NA
分子式: C21H25NO5
分子量: 371.4
投资状态: Custom Synthesis

Samidorphan Impurity 3

SZ目录编号:: SZ-S083006
CAS 号: 421552-35-4
分子式: C21H24N2O4
分子量: 368.4
投资状态: Custom Synthesis

Samidorphan Isoquinoline Dioxolane

SZ目录编号:: SZ-S083005
CAS 号: 361525-83-9
分子式: C23H28N2O5
分子量: 412.5
投资状态: Custom Synthesis

Samidorphan L-Malate

SZ目录编号:: SZ-S083004
CAS 号: 1204592-75-5
分子式: C21H26N2O4 : C4H6O5
分子量: 370.4 : 134.1
投资状态: Custom Synthesis

Samidorphan D4

SZ目录编号:: SZ-S083D01
CAS 号: NA
分子式: C21H22D4N2O4
分子量: 374.5
投资状态: Custom Synthesis

Samidorphan D5

SZ目录编号:: SZ-S083D02
CAS 号: NA
分子式: C21H21D5N2O4
分子量: 375.5
投资状态:

Samidorphan D7

SZ目录编号:: SZ-S083D03
CAS 号: NA
分子式: C21H19D7N2O4
分子量: 377.5
投资状态:

Samidorphan Nitroso Impurity 1

SZ目录编号:: SZ-S083008
CAS 号: NA
分子式: C17H19N3O5
分子量: 345.4
投资状态: Custom Synthesis
categories